NUMB
gene geneOn this page
Summary
NUMB (NUMB endocytic adaptor protein, HGNC:8060) is a protein-coding gene on chromosome 14q24.3, encoding Protein numb homolog (P49757). Regulates clathrin-mediated receptor endocytosis.
The protein encoded by this gene plays a role in the determination of cell fates during development. The encoded protein, whose degradation is induced in a proteasome-dependent manner by MDM2, is a membrane-bound protein that has been shown to associate with EPS15, LNX1, and NOTCH1. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 8650 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 92 total
- MANE Select transcript:
NM_001005743
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8060 |
| Approved symbol | NUMB |
| Name | NUMB endocytic adaptor protein |
| Location | 14q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000133961 |
| Ensembl biotype | protein_coding |
| OMIM | 603728 |
| Entrez | 8650 |
Gene structure
Transcript identifiers
Ensembl transcripts: 155 — 139 protein_coding, 10 protein_coding_CDS_not_defined, 6 retained_intron
ENST00000355058, ENST00000356296, ENST00000359560, ENST00000535282, ENST00000544991, ENST00000553415, ENST00000553997, ENST00000554014, ENST00000554315, ENST00000554394, ENST00000554521, ENST00000554546, ENST00000554818, ENST00000555238, ENST00000555307, ENST00000555394, ENST00000555738, ENST00000555859, ENST00000555987, ENST00000556112, ENST00000556600, ENST00000556700, ENST00000556772, ENST00000556989, ENST00000557031, ENST00000557486, ENST00000557577, ENST00000557581, ENST00000557597, ENST00000557774, ENST00000559312, ENST00000560335, ENST00000643731, ENST00000646944, ENST00000647202, ENST00000863595, ENST00000863596, ENST00000863597, ENST00000863598, ENST00000863599, ENST00000863600, ENST00000863601, ENST00000863602, ENST00000863603, ENST00000863604, ENST00000863605, ENST00000863606, ENST00000863607, ENST00000863608, ENST00000863609, ENST00000863610, ENST00000863611, ENST00000863612, ENST00000863613, ENST00000863614, ENST00000863615, ENST00000863616, ENST00000863617, ENST00000863618, ENST00000863619, ENST00000863620, ENST00000863621, ENST00000863622, ENST00000863623, ENST00000863624, ENST00000863625, ENST00000863626, ENST00000863627, ENST00000863628, ENST00000863629, ENST00000863630, ENST00000863631, ENST00000863632, ENST00000863633, ENST00000863634, ENST00000863635, ENST00000863636, ENST00000863637, ENST00000863638, ENST00000863639, ENST00000863640, ENST00000863641, ENST00000863642, ENST00000863643, ENST00000863644, ENST00000863645, ENST00000863646, ENST00000863647, ENST00000863648, ENST00000863649, ENST00000863650, ENST00000863651, ENST00000863652, ENST00000863653, ENST00000863655, ENST00000863656, ENST00000863657, ENST00000863661, ENST00000863662, ENST00000863663, ENST00000863664, ENST00000863665, ENST00000863666, ENST00000863667, ENST00000863668, ENST00000863669, ENST00000863670, ENST00000863671, ENST00000863672, ENST00000925283, ENST00000925284, ENST00000925285, ENST00000925286, ENST00000925287, ENST00000925288, ENST00000925289, ENST00000925290, ENST00000925291, ENST00000925292, ENST00000925293, ENST00000925294, ENST00000925295, ENST00000925296, ENST00000957445, ENST00000957446, ENST00000957447, ENST00000957448, ENST00000957449, ENST00000957450, ENST00000957451, ENST00000957452, ENST00000957453, ENST00000957454, ENST00000957455, ENST00000957456, ENST00000957457, ENST00000957458, ENST00000957459, ENST00000957460, ENST00000957461, ENST00000957462, ENST00000957463, ENST00000957464, ENST00000957465, ENST00000957466, ENST00000957467, ENST00000957468, ENST00000957469, ENST00000957470, ENST00000957471, ENST00000957472, ENST00000957473, ENST00000957474, ENST00000957475, ENST00000957476
RefSeq mRNA: 5 — MANE Select: NM_001005743
NM_001005743, NM_001005744, NM_001005745, NM_001320114, NM_003744
CCDS: CCDS32115, CCDS32116, CCDS55927, CCDS9814
Canonical transcript exons
ENST00000555238 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001689532 | 73279281 | 73279424 |
| ENSE00002228686 | 73458493 | 73458546 |
| ENSE00002505332 | 73275216 | 73277293 |
| ENSE00003495034 | 73297211 | 73297285 |
| ENSE00003573756 | 73282359 | 73282505 |
| ENSE00003612959 | 73316390 | 73316422 |
| ENSE00003626002 | 73292734 | 73292874 |
| ENSE00003633138 | 73287110 | 73287314 |
| ENSE00003635053 | 73355626 | 73355766 |
| ENSE00003662648 | 73284081 | 73284374 |
| ENSE00003791033 | 73323130 | 73323204 |
| ENSE00003828472 | 73366897 | 73366981 |
| ENSE00003830790 | 73409937 | 73410068 |
Expression profiles
Bgee: expression breadth ubiquitous, 284 present calls, max score 97.49.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 42.9683 / max 884.4999, expressed in 1818 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 143962 | 41.4991 | 1817 |
| 143961 | 1.2859 | 495 |
| 143958 | 0.1315 | 39 |
| 143959 | 0.0518 | 6 |
Top tissues by expression
291 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 97.49 | gold quality |
| colonic epithelium | UBERON:0000397 | 97.29 | gold quality |
| mononuclear cell | CL:0000842 | 96.92 | gold quality |
| leukocyte | CL:0000738 | 96.81 | gold quality |
| right lung | UBERON:0002167 | 96.68 | gold quality |
| blood | UBERON:0000178 | 96.17 | gold quality |
| gall bladder | UBERON:0002110 | 95.85 | gold quality |
| right uterine tube | UBERON:0001302 | 95.74 | gold quality |
| stromal cell of endometrium | CL:0002255 | 95.69 | gold quality |
| rectum | UBERON:0001052 | 95.66 | gold quality |
| oocyte | CL:0000023 | 95.64 | gold quality |
| sural nerve | UBERON:0015488 | 95.32 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 95.27 | gold quality |
| secondary oocyte | CL:0000655 | 94.90 | gold quality |
| minor salivary gland | UBERON:0001830 | 94.64 | gold quality |
| metanephros cortex | UBERON:0010533 | 94.58 | gold quality |
| buccal mucosa cell | CL:0002336 | 94.56 | gold quality |
| left uterine tube | UBERON:0001303 | 94.54 | gold quality |
| body of uterus | UBERON:0009853 | 94.52 | gold quality |
| lower esophagus | UBERON:0013473 | 94.44 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 94.44 | gold quality |
| upper lobe of lung | UBERON:0008948 | 94.42 | gold quality |
| transverse colon | UBERON:0001157 | 94.37 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 94.30 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 94.12 | gold quality |
| tibial nerve | UBERON:0001323 | 94.01 | gold quality |
| body of pancreas | UBERON:0001150 | 94.00 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 93.92 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 93.88 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 93.87 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-135 | no | 901.08 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): HES1, HNF4A, KLF8, MSI2, SATB1
miRNA regulators (miRDB)
141 targeting NUMB, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-4713-3P | 100.00 | 65.92 | 505 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-1229-3P | 99.97 | 66.49 | 906 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
Literature-anchored findings (GeneRIF, showing 40)
- These data strongly suggest that Mdm2 functions as the ubiquitin ligase toward hNumb and that it induces its degradation in intact cells. (PMID:12646252)
- the Numb/Notch biological antagonism has a role in homeostasis of the normal mammary parenchyma and its subversion contributes to human mammary carcinogenesis (PMID:15492044)
- These results highlight a role of Numb for dendritic spine development and synaptic functions with intersectin and EphB2. (PMID:16394100)
- The two distinct types of hNumb isoforms could contribute to different phases of neurogenesis in the embryonic CNS. (PMID:16508311)
- Epigenetic silencing, deletion and loss-of-function mutation of NUMB gene could lead to carcinogenesis through the dysregulation of the WNT - Notch signaling cycle. (PMID:16865239)
- Hedgehog transcription factor Gli1 is targeted by Numb for Itch-dependent ubiquitination, which suppresses Hedgehog signals, thus arresting growth and promoting cell differentiation. (PMID:17115028)
- significantly lower expressions of Notch1, Jagged1, Numb, and Delta-like 1 were evident in muscle biopsies from older men (60-75 years old) compared to muscle from younger men (18-25 years old). (PMID:17301032)
- Because Numb interacts with the aPKC binding partner PAR-3, we propose a model in which polarized Numb phosphorylation contributes to cell migration by directing integrin endocytosis to the leading edge (PMID:17609107)
- NUMB enters in a tricomplex with p53 and the E3 ubiquitin ligase HDM2 (also known as MDM2), thereby preventing ubiquitination and degradation of p53 (PMID:18172499)
- Numb is implicated in aberrant differentiation programs of salivary gland carcinomas (PMID:18179751)
- Numb expression in astrocytomas recapitulates that of progenitor cells during neurodevelopment, and suggests a role for Numb in astrocytoma oncogenesis. (PMID:18384513)
- Numb endocytic adapter proteins regulate the transport and processing of the amyloid precursor protein in an isoform-dependent manner and have roles in Alzheimer disease pathogenesis (PMID:18599481)
- These observations demonstrate that Numb3 is an endocytic receptor for P-selectin and may be responsible for the rapid internalization of P-selectin when endothelial activation ends. (PMID:19138666)
- Numb promotes neuronal differentiation by a mechanism involving PTB domain-specific regulation of Ca2+ influx and MAP kinase activation. (PMID:19344753)
- Expression of Numb protein in Cervical squamous epithelia may be among the mechanisms involved in the genesis of cervical squamous cell carcinomas (PMID:19468255)
- Results indicate that loss of Numb expression is a marker of tumor aggressiveness, potentially linked to BRCA1 status and a cancer stem cell phenotype in primary breast cancer. (PMID:19795205)
- Numb activates the catalytic activity of Itch, releasing it from an inhibitory intramolecular interaction between its homologous to E6-AP C-terminus and WW domains. (PMID:20818436)
- we report the identification ofthe novel isoforms, NUMB5 and NUMB6, and propose a link between the expression of these isoforms and cancer (PMID:21122105)
- cell migration studies revealed NUMB isoform 1 to be involved in EVT cell migration and NUMB isoforms 2 and 4 to induce EVT apoptosis (PMID:21486681)
- atypical protein kinase C phosphorylates Numb to prevent its binding to p120 and alpha-adaptin, thereby attenuating E-cadherin endocytosis to maintain apicobasal polarity (PMID:21775625)
- NUMB is consistently expressed in glioma biopsies with predominance of NUMB2/4 isoforms as determined by isoform-specific real-time PCR and Western blotting. (PMID:21939656)
- analysis of MDM2 protein-mediated ubiquitination of numb protein (PMID:22337874)
- Numb has an important regulation in the process of colon cancer progression and may play a protective role against tumor development. (PMID:22455121)
- Numb regulates glioma stem cell fate and growth by altering epidermal growth factor receptor and Skp1-Cullin-F-box ubiquitin ligase activity (PMID:22553175)
- Dysregulation of Numb expression results in mislocalized Plk1 and poor centrosomal gamma-tubulin recruitment, potentially contributing to mitotic errors, aneuploidy, and cancer development. (PMID:22593191)
- This study implies that any mutations within the NUMB gene that might influence the disease course of chronic myeloid leukemia are very rare. (PMID:22734830)
- Down-modulation of NUMB is associated with myelodysplastic syndromes and acute myeloid leukemia. (PMID:22784712)
- Numb1 interacts with TRPV6 through charged residues and inhibits its activity via the regulation of protein expression. (PMID:23140583)
- Expression of stem cell regulator NUMB is not associated with any prognostic significance in acute myeloid leukemia patients. (PMID:23233047)
- Overexpression of Numb inhibited proliferation, promoted apoptosis and enhanced sensitivity to cisplatin, and activated caspase-9 and caspase-3 through release of cytochrome c as well as downregulation of XIAP and survivin. (PMID:23624653)
- Data indicate the Set8-Numb-p53 signaling axis as an important regulatory pathway for apoptosis and suggests a therapeutic strategy by targeting Numb methylation. (PMID:23706821)
- The Numb modulates the paracellular permeability by affecting apical junctional complex (AJC) assembly and myosin light chain (MLC) phosphorylation. (PMID:23872314)
- The study demonstrates coordinated regulation of Numb, MDM2 and p53 on cell invasion and migration in pancreatic cancer. (PMID:23881403)
- miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes. (PMID:24302991)
- Identify the Notch pathway regulator NUMB as a key target of these factors. (PMID:24332178)
- Numb up-regulation significantly correlates with cell proliferation and poor prognosis in hepatocellular carcinoma patients. (PMID:24770339)
- Findings suggested NUMB-1 functions as a tumor-suppressor and serves as a prognositc biomarker for ESCC patients. (PMID:24980814)
- Numb specifically regulates NPC1L1-mediated cholesterol absorption both in human intestine and liver, distinct from ARH and Dab2, which selectively participate in LDLR-mediated LDL uptake. (PMID:25331956)
- Using LC-MS/MS, the study reports the identification of 25 serine/threonine Numb phosphorylation sites, and a single tyrosine phosphorylation site. (PMID:25403733)
- Taken together, our data suggest that Numb may possibly function as a tumor suppressor involved in the carcinogenesis of clear cell renal cell carcinoma (PMID:25480416)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | numb | ENSDARG00000027279 |
| mus_musculus | Numb | ENSMUSG00000021224 |
| rattus_norvegicus | Numb | ENSRNOG00000009653 |
| drosophila_melanogaster | numb | FBGN0002973 |
| drosophila_melanogaster | CG8312 | FBGN0037720 |
| caenorhabditis_elegans | WBGENE00003830 | |
| caenorhabditis_elegans | WBGENE00009930 |
Paralogs (11): MAPK8IP2 (ENSG00000008735), NUMBL (ENSG00000105245), MAPK8IP1 (ENSG00000121653), GULP1 (ENSG00000144366), DAB2 (ENSG00000153071), LDLRAP1 (ENSG00000157978), DAB1 (ENSG00000173406), FAM43B (ENSG00000183114), FAM43A (ENSG00000185112), NOS1AP (ENSG00000198929), C1orf226 (ENSG00000239887)
Protein
Protein identifiers
Protein numb homolog — P49757 (reviewed: P49757)
Alternative names: Protein S171
All UniProt accessions (6): P49757, G3V3M5, G3V3R1, G3V3Z8, G3V433, G3V4S6
UniProt curated annotations — full annotation on UniProt →
Function. Regulates clathrin-mediated receptor endocytosis. Plays a role in the process of neurogenesis. Required throughout embryonic neurogenesis to maintain neural progenitor cells, also called radial glial cells (RGCs), by allowing their daughter cells to choose progenitor over neuronal cell fate. Not required for the proliferation of neural progenitor cells before the onset of neurogenesis. Also involved postnatally in the subventricular zone (SVZ) neurogenesis by regulating SVZ neuroblasts survival and ependymal wall integrity. May also mediate local repair of brain ventricular wall damage.
Subunit / interactions. Interacts with SIAH1. Interacts with LNX. Interacts with CDH1. Interacts with TFAP2A and TFAP2B. Interacts with RALBP1 in a complex also containing EPN1 and TFAP2A during interphase and mitosis. Interacts with AAK1. May interact with DUOXA1.
Subcellular location. Cell membrane. Endosome membrane.
Post-translational modifications. Phosphorylated on Ser-276 and Ser-295 by CaMK1. Isoform 1 and isoform 2 are ubiquitinated by LNX leading to their subsequent proteasomal degradation. Ubiquitinated; mediated by SIAH1 and leading to its subsequent proteasomal degradation.
Isoforms (9)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P49757-1 | 1, p72 | yes |
| P49757-2 | 2, p66 | |
| P49757-3 | 3, p71 | |
| P49757-4 | 4, p65 | |
| P49757-5 | 5 | |
| P49757-6 | 6 | |
| P49757-7 | 7 | |
| P49757-8 | 8 | |
| P49757-9 | 9 |
RefSeq proteins (5): NP_001005743, NP_001005744, NP_001005745, NP_001307043, NP_003735 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006020 | PTB/PI_dom | Domain |
| IPR010449 | Numb_domain | Domain |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR016698 | Numb/numb-like | Family |
Pfam: PF00640, PF06311
UniProt features (48 total): modified residue 10, strand 8, splice variant 5, sequence conflict 5, helix 5, compositionally biased region 4, region of interest 3, turn 3, sequence variant 2, chain 1, domain 1, mutagenesis site 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 5NJJ | X-RAY DIFFRACTION | 2.7 |
| 5NJK | X-RAY DIFFRACTION | 3.13 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P49757-F1 | 60.47 | 0.19 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (10): 194, 243, 244, 276, 295, 425, 436, 438, 634, 102
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 102 | loss of aak1-mediated phosphorylation. |
Function
Pathways and Gene Ontology
Reactome pathways
5 pathways
| ID | Pathway |
|---|---|
| R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus |
| R-HSA-437239 | Recycling pathway of L1 |
| R-HSA-5610780 | Degradation of GLI1 by the proteasome |
| R-HSA-5632684 | Hedgehog ‘on’ state |
| R-HSA-9725554 | Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin |
MSigDB gene sets: 292 (showing top):
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, REACTOME_SIGNALING_BY_NOTCH, TGCGCANK_UNKNOWN, MORF_ATRX, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, TATTATA_MIR374, GOBP_NEUROGENESIS, GOBP_VESICLE_MEDIATED_TRANSPORT, TACAATC_MIR508, GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, GOBP_VENTRICULAR_SYSTEM_DEVELOPMENT, GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, GOBP_CELL_PROLIFERATION_IN_FOREBRAIN, GOBP_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY
GO Biological Process (12): axonogenesis (GO:0007409), lateral ventricle development (GO:0021670), neuroblast division in subventricular zone (GO:0021849), regulation of endocytosis (GO:0030100), positive regulation of cell migration (GO:0030335), adherens junction organization (GO:0034332), positive regulation of neurogenesis (GO:0050769), regulation of postsynaptic neurotransmitter receptor internalization (GO:0099149), negative regulation of protein localization to plasma membrane (GO:1903077), nervous system development (GO:0007399), neuroblast proliferation (GO:0007405), forebrain development (GO:0030900)
GO Molecular Function (4): beta-catenin binding (GO:0008013), alpha-catenin binding (GO:0045294), cadherin binding (GO:0045296), protein binding (GO:0005515)
GO Cellular Component (13): cytoplasm (GO:0005737), early endosome (GO:0005769), plasma membrane (GO:0005886), clathrin-coated pit (GO:0005905), focal adhesion (GO:0005925), endosome membrane (GO:0010008), basolateral plasma membrane (GO:0016323), clathrin-coated vesicle (GO:0030136), cytoplasmic vesicle (GO:0031410), apical part of cell (GO:0045177), glutamatergic synapse (GO:0098978), endosome (GO:0005768), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Signaling by NOTCH1 | 1 |
| L1CAM interactions | 1 |
| Hedgehog ‘off’ state | 1 |
| Signaling by Hedgehog | 1 |
| Developmental Cell Lineages of the Integumentary System | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| anatomical structure development | 2 |
| protein binding | 2 |
| endosome | 2 |
| membrane | 2 |
| endomembrane system | 2 |
| cell morphogenesis involved in neuron differentiation | 1 |
| neuron projection morphogenesis | 1 |
| axon development | 1 |
| telencephalon development | 1 |
| ventricular system development | 1 |
| cell proliferation in forebrain | 1 |
| neuroblast division | 1 |
| endocytosis | 1 |
| regulation of cellular component organization | 1 |
| regulation of vesicle-mediated transport | 1 |
| cell migration | 1 |
| regulation of cell migration | 1 |
| positive regulation of cell motility | 1 |
| cell-cell junction organization | 1 |
| positive regulation of cell development | 1 |
| neurogenesis | 1 |
| regulation of neurogenesis | 1 |
| positive regulation of nervous system development | 1 |
| regulation of receptor internalization | 1 |
| regulation of biological quality | 1 |
| postsynaptic neurotransmitter receptor internalization | 1 |
| protein localization to plasma membrane | 1 |
| regulation of protein localization to plasma membrane | 1 |
| negative regulation of protein localization to cell periphery | 1 |
| negative regulation of protein localization to membrane | 1 |
| system development | 1 |
| generation of neurons | 1 |
| neural precursor cell proliferation | 1 |
| brain development | 1 |
| cell adhesion molecule binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cell periphery | 1 |
| cell-substrate junction | 1 |
Protein interactions and networks
STRING
2410 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NUMB | MDM2 | Q00987 | 990 |
| NUMB | LNX1 | Q8TBB1 | 980 |
| NUMB | EPS15 | P42566 | 973 |
| NUMB | DPYSL2 | Q16555 | 946 |
| NUMB | MSI2 | Q96DH6 | 930 |
| NUMB | LNX2 | Q8N448 | 878 |
| NUMB | CDH1 | P12830 | 860 |
| NUMB | NOTCH1 | P46531 | 849 |
| NUMB | ITCH | Q96J02 | 815 |
| NUMB | MSI1 | O43347 | 799 |
| NUMB | JAG1 | P78504 | 753 |
| NUMB | NOTCH2 | Q04721 | 738 |
| NUMB | CDH17 | Q12864 | 733 |
| NUMB | SH3BP4 | Q9P0V3 | 726 |
| NUMB | PARD3 | Q8TEW0 | 712 |
IntAct
128 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MDM2 | TP53 | psi-mi:“MI:0914”(association) | 1.000 |
| MDM2 | TP53 | psi-mi:“MI:0915”(physical association) | 1.000 |
| YWHAB | PIK3C2A | psi-mi:“MI:0914”(association) | 0.800 |
| EPS15 | NUMB | psi-mi:“MI:0407”(direct interaction) | 0.750 |
| EPS15 | NUMB | psi-mi:“MI:0915”(physical association) | 0.750 |
| KBTBD7 | METTL15 | psi-mi:“MI:0914”(association) | 0.730 |
| MDM2 | NUMB | psi-mi:“MI:0915”(physical association) | 0.720 |
| MDM2 | NUMB | psi-mi:“MI:0407”(direct interaction) | 0.720 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| YWHAG | BLTP3B | psi-mi:“MI:0914”(association) | 0.640 |
| YWHAG | BLTP3B | psi-mi:“MI:2364”(proximity) | 0.640 |
| STAMBPL1 | PIK3C2A | psi-mi:“MI:0914”(association) | 0.640 |
| NUMB | SLC1A1 | psi-mi:“MI:0914”(association) | 0.640 |
| SLC1A1 | AGPAT2 | psi-mi:“MI:0914”(association) | 0.640 |
| SNX9 | WASL | psi-mi:“MI:0914”(association) | 0.640 |
| NUMB | TP53 | psi-mi:“MI:0914”(association) | 0.630 |
| TP53 | NUMB | psi-mi:“MI:0407”(direct interaction) | 0.630 |
| TP53 | NUMB | psi-mi:“MI:0914”(association) | 0.630 |
| NUMB | TP53 | psi-mi:“MI:0407”(direct interaction) | 0.630 |
| YWHAB | BLTP3B | psi-mi:“MI:2364”(proximity) | 0.610 |
| IGF1R | PIK3R2 | psi-mi:“MI:2364”(proximity) | 0.590 |
| YWHAE | PIK3C2A | psi-mi:“MI:0914”(association) | 0.570 |
| YWHAH | BLTP3B | psi-mi:“MI:0914”(association) | 0.570 |
| YWHAH | BLTP3B | psi-mi:“MI:2364”(proximity) | 0.570 |
BioGRID (363): NUMB (Affinity Capture-MS), NUMB (Two-hybrid), OLIG1 (Two-hybrid), NUMB (Two-hybrid), LNX2 (Two-hybrid), NUMB (Two-hybrid), TERF2 (Two-hybrid), NUMB (Proximity Label-MS), NUMB (Affinity Capture-MS), NUMB (Affinity Capture-MS), NUMB (Affinity Capture-MS), NUMB (Affinity Capture-MS), NUMB (Affinity Capture-MS), NUMB (Affinity Capture-MS), NUMB (Affinity Capture-MS)
ESM2 similar proteins: A1L1I3, A5PKW4, O08919, O70405, O75385, O75420, O75553, P16554, P42128, P49757, P53814, P85037, P97318, P98081, Q04637, Q2LC84, Q3UCQ1, Q4KMP7, Q5DTT2, Q5I1X5, Q5RBR0, Q5VZ18, Q69ZH9, Q69ZI1, Q7TN02, Q7Z6J0, Q80VC9, Q80XI3, Q80Z38, Q86V15, Q8BGT6, Q8BHL3, Q8BSD5, Q8C120, Q8CI12, Q8IY33, Q8K4J6, Q8N3F8, Q8TEH3, Q8TEJ3
Diamond homologs: A1L1I3, O08919, O88797, P16554, P49757, P98078, P98081, P98082, Q2LC84, Q5PQS4, Q5SW96, Q801G1, Q8C142, Q8K2A1, Q9QZS3, Q9UBP9, Q9XTY6, Q9Y6R0, O75553, P97318, Q8CJH2, Q9BGX5, Q67FQ3, A5PMU4, D3ZAR1, Q32PV0, P0C6S7, Q8BIZ1
SIGNOR signaling
21 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| LNX1 | down-regulates | NUMB | ubiquitination |
| SIAH1 | down-regulates | NUMB | ubiquitination |
| SLC30A9 | “down-regulates quantity by destabilization” | NUMB | ubiquitination |
| CAMK1 | down-regulates | NUMB | phosphorylation |
| PRKCI | down-regulates | NUMB | phosphorylation |
| MSI1 | down-regulates | NUMB | binding |
| NUMB | down-regulates | GLI1 | binding |
| NUMB | up-regulates | ITCH | binding |
| NUMB | down-regulates | MDM2 | binding |
| NUMB | up-regulates | TP53 | |
| MSI2 | “down-regulates quantity by repression” | NUMB | “transcriptional regulation” |
| NUMB | up-regulates | TP53 | binding |
| AAK1 | up-regulates | NUMB | phosphorylation |
| AAK1 | unknown | NUMB | phosphorylation |
| SATB1 | “down-regulates quantity by repression” | NUMB | “transcriptional regulation” |
| LNX2 | “down-regulates quantity by destabilization” | NUMB | ubiquitination |
| MDM2 | down-regulates | NUMB | ubiquitination |
| NUMB | “down-regulates quantity by destabilization” | NOTCH1 | ubiquitination |
| NUMB | down-regulates | NOTCH | |
| LNX2 | “down-regulates quantity by destabilization” | NUMB | polyubiquitination |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 127 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 8 | 51.2× | 2e-10 |
| Activation of BAD and translocation to mitochondria | 7 | 50.8× | 3e-09 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | 7 | 44.8× | 7e-09 |
| WNT5A-dependent internalization of FZD4 | 6 | 43.5× | 2e-07 |
| VLDLR internalisation and degradation | 5 | 34.0× | 8e-06 |
| Activation of BH3-only proteins | 7 | 33.1× | 7e-08 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 5 | 30.2× | 1e-05 |
| The role of Nef in HIV-1 replication and disease pathogenesis | 5 | 30.2× | 1e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| clathrin coat assembly | 7 | 54.5× | 3e-08 |
| clathrin-dependent endocytosis | 7 | 35.7× | 3e-07 |
| synaptic vesicle endocytosis | 7 | 26.5× | 2e-06 |
| protein targeting | 5 | 16.1× | 2e-03 |
| insulin receptor signaling pathway | 6 | 11.7× | 2e-03 |
| epidermal growth factor receptor signaling pathway | 5 | 10.9× | 8e-03 |
| cell surface receptor protein tyrosine kinase signaling pathway | 6 | 9.1× | 6e-03 |
| intracellular protein localization | 8 | 7.3× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
92 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 73 |
| Likely benign | 2 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1726 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:73277291:TCCC:T | acceptor_loss | 1.0000 |
| 14:73277292:CCCT:C | acceptor_loss | 1.0000 |
| 14:73277294:CTGG:C | acceptor_loss | 1.0000 |
| 14:73277302:A:T | acceptor_gain | 1.0000 |
| 14:73282506:C:CC | acceptor_gain | 1.0000 |
| 14:73284288:C:CT | acceptor_gain | 1.0000 |
| 14:73284378:A:T | acceptor_gain | 1.0000 |
| 14:73287109:CCTTT:C | donor_gain | 1.0000 |
| 14:73292732:A:AC | donor_gain | 1.0000 |
| 14:73292733:C:CC | donor_gain | 1.0000 |
| 14:73323128:A:AC | donor_gain | 1.0000 |
| 14:73323128:ACAG:A | donor_gain | 1.0000 |
| 14:73323129:C:CC | donor_gain | 1.0000 |
| 14:73323129:CAG:C | donor_gain | 1.0000 |
| 14:73323129:CAGC:C | donor_gain | 1.0000 |
| 14:73323201:GGTA:G | acceptor_gain | 1.0000 |
| 14:73323205:C:CC | acceptor_gain | 1.0000 |
| 14:73355622:TTAC:T | donor_loss | 1.0000 |
| 14:73355623:TACC:T | donor_loss | 1.0000 |
| 14:73355624:A:AC | donor_gain | 1.0000 |
| 14:73355624:A:AT | donor_loss | 1.0000 |
| 14:73355625:C:CC | donor_gain | 1.0000 |
| 14:73355625:CCT:C | donor_gain | 1.0000 |
| 14:73355627:TTA:T | donor_gain | 1.0000 |
| 14:73277292:CC:C | acceptor_gain | 0.9900 |
| 14:73277293:CC:C | acceptor_gain | 0.9900 |
| 14:73277294:C:CC | acceptor_gain | 0.9900 |
| 14:73277295:T:A | acceptor_loss | 0.9900 |
| 14:73277301:C:CT | acceptor_gain | 0.9900 |
| 14:73277304:C:CT | acceptor_gain | 0.9900 |
AlphaMissense
4255 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:73277205:C:A | W443C | 1.000 |
| 14:73277205:C:G | W443C | 1.000 |
| 14:73277207:A:G | W443R | 1.000 |
| 14:73277207:A:T | W443R | 1.000 |
| 14:73284143:A:G | L296P | 1.000 |
| 14:73284160:A:C | F290L | 1.000 |
| 14:73284160:A:T | F290L | 1.000 |
| 14:73284161:A:C | F290C | 1.000 |
| 14:73284161:A:G | F290S | 1.000 |
| 14:73284162:A:G | F290L | 1.000 |
| 14:73284213:G:T | R273S | 1.000 |
| 14:73284243:G:T | R263S | 1.000 |
| 14:73287180:G:C | F195L | 1.000 |
| 14:73287180:G:T | F195L | 1.000 |
| 14:73287181:A:G | F195S | 1.000 |
| 14:73287182:A:G | F195L | 1.000 |
| 14:73287187:C:T | G193E | 1.000 |
| 14:73287188:C:G | G193R | 1.000 |
| 14:73287188:C:T | G193R | 1.000 |
| 14:73287192:T:A | R191S | 1.000 |
| 14:73287192:T:G | R191S | 1.000 |
| 14:73287193:C:A | R191I | 1.000 |
| 14:73287193:C:G | R191T | 1.000 |
| 14:73287198:A:C | F189L | 1.000 |
| 14:73287198:A:T | F189L | 1.000 |
| 14:73287199:A:C | F189C | 1.000 |
| 14:73287199:A:G | F189S | 1.000 |
| 14:73287200:A:G | F189L | 1.000 |
| 14:73287226:G:T | A180D | 1.000 |
| 14:73287250:C:G | R172P | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000007981 (14:73374886 A>G), RS1000008500 (14:73323018 T>A,C), RS1000041711 (14:73369043 T>C), RS1000062392 (14:73278153 G>A), RS1000092657 (14:73413147 T>A,C), RS1000102325 (14:73373063 C>T), RS1000149215 (14:73351992 T>A), RS1000154422 (14:73416484 G>A), RS1000188209 (14:73439754 T>C), RS1000208294 (14:73297755 C>T), RS1000217904 (14:73440091 A>G), RS1000237967 (14:73298067 C>G,T), RS1000262902 (14:73345243 G>A), RS1000271361 (14:73318746 G>A), RS1000311896 (14:73309125 G>A)
Disease associations
OMIM: gene MIM:603728 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000097_2 | Coronary artery calcification | 6.000000e-06 |
| GCST001715_4 | Bipolar disorder with mood-incongruent psychosis | 7.000000e-07 |
| GCST006976_61 | Macular thickness | 4.000000e-10 |
| GCST008512_32 | Multisite chronic pain | 4.000000e-08 |
| GCST011954_5 | White matter hyperintensity volume x hypertension interaction (2df) | 3.000000e-08 |
| GCST012332_40 | Multisite chronic pain | 5.000000e-08 |
| GCST90002384_368 | Hemoglobin | 7.000000e-15 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004723 | coronary artery calcification |
| EFO:0010100 | multisite chronic pain |
| EFO:0005665 | white matter hyperintensity measurement |
| EFO:0004509 | hemoglobin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
49 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| methacrylaldehyde | increases oxidation, increases abundance, affects cotreatment, decreases expression | 2 |
| Acrolein | affects cotreatment, decreases expression, increases oxidation, increases abundance | 2 |
| Ozone | increases oxidation, increases abundance, affects cotreatment, decreases expression | 2 |
| FR900359 | affects phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | increases oxidation, increases abundance, affects cotreatment, decreases expression | 1 |
| bisphenol A | decreases expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| sodium arsenite | increases expression | 1 |
| potassium chromate(VI) | decreases expression, affects cotreatment | 1 |
| coumarin | increases phosphorylation | 1 |
| beta-methylcholine | affects expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene | affects cotreatment, increases expression | 1 |
| N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | increases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | increases expression | 1 |
| bisphenol B | increases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| bisphenol AF | increases expression | 1 |
| Bortezomib | increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Arsenic Trioxide | decreases expression | 1 |
| Norethindrone Acetate | affects cotreatment, increases expression | 1 |
| Air Pollutants | increases oxidation, affects cotreatment, decreases expression, increases abundance | 1 |
| Vehicle Emissions | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Caffeine | affects phosphorylation | 1 |
| Cisplatin | decreases expression | 1 |
| Demecolcine | increases expression | 1 |
Cellosaurus cell lines
8 cell lines: 7 cancer cell line, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D7W8 | Ubigene A-549 NUMB KO | Cancer cell line | Male |
| CVCL_D8RR | Ubigene HCT 116 NUMB KO | Cancer cell line | Male |
| CVCL_D9LS | Ubigene HEK293 NUMB KO | Transformed cell line | Female |
| CVCL_E0JE | Ubigene HeLa NUMB KO | Cancer cell line | Female |
| CVCL_F1M8 | HyCyte A-549 KO-hNUMB | Cancer cell line | Male |
| CVCL_TB46 | HAP1 NUMB (-) 1 | Cancer cell line | Male |
| CVCL_XR24 | HAP1 NUMB (-) 2 | Cancer cell line | Male |
| CVCL_XR25 | HAP1 NUMB (-) 3 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.